Hypofractionated reirradiation for recurrent malignant glioma. (Q48727610)

15 February 2018

title

Hypofractionated reirradiation for recurrent malignant glioma. (English)

1 reference

15 February 2018

8

Claus Belka

1 reference

15 February 2018

author name string

Guido Henke

1

1 reference

15 February 2018

Frank Paulsen

2

1 reference

15 February 2018

Joachim P Steinbach

3

1 reference

15 February 2018

Ute Ganswindt

4

1 reference

15 February 2018

Hana Isijanov

5

1 reference

15 February 2018

Rolf-Dieter Kortmann

6

1 reference

15 February 2018

Michael Bamberg

7

1 reference

15 February 2018

publication date

25 February 2009

1 reference

15 February 2018

Strahlentherapie und Onkologie

published in

1 reference

15 February 2018

volume

185

1 reference

15 February 2018

issue

2

1 reference

15 February 2018

page(s)

113-119

1 reference

15 February 2018

https://scigraph.springernature.com/pub.10.1007/s00066-009-1969-9

exact match

0 references

cites work

Reirradiation and lomustine in patients with relapsed high-grade gliomas

1 reference

https://api.crossref.org/works/10.1007%2FS00066-009-1969-9

Reirradiation of recurrent high-grade gliomas using amino acid PET (SPECT)/CT/MRI image fusion to determine gross tumor volume for stereotactic fractionated radiotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00066-009-1969-9

A phase I dose escalation study of hypofractionated stereotactic radiotherapy as salvage therapy for persistent or recurrent malignant glioma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00066-009-1969-9

Patterns of failure following high-dose 3-D conformal radiotherapy for high-grade astrocytomas: a quantitative dosimetric study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00066-009-1969-9

Survival and quality of life after interstitial implantation of removable high-activity iodine-125 sources for the treatment of patients with recurrent malignant gliomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00066-009-1969-9

A phase I dose-escalation study of fractionated stereotactic radiosurgery in combination with gefitinib in patients with recurrent malignant gliomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00066-009-1969-9

Hypofractionated stereotactic radiotherapy in the management of recurrent glioma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00066-009-1969-9

Efficacy of fractionated stereotactic reirradiation in recurrent gliomas: long-term results in 172 patients treated in a single institution.

21 January 2018

1 reference

12 December 2020

Survival and functional status after resection of recurrent glioblastoma multiforme.

1 reference

12 December 2020

Is reoperation for recurrence of glioblastoma justified?

1 reference

12 December 2020

Stereotactically guided fractionated re-irradiation in recurrent glioblastoma multiforme

1 reference

12 December 2020

Case-control study of stereotactic radiosurgery for recurrent glioblastoma multiforme.

1 reference

12 December 2020

Hypofractionated stereotactic re-irradiation: treatment option in recurrent malignant glioma

1 reference

12 December 2020

Repeated surgery for glioblastoma multiforme: only in combination with other salvage therapy.

1 reference

12 December 2020

Temozolomide 3 weeks on and 1 week off as first-line therapy for recurrent glioblastoma: phase II study from gruppo italiano cooperativo di neuro-oncologia (GICNO).

1 reference

12 December 2020

Surgery for glioma relapse. Factors that influence a favorable outcome.

1 reference

12 December 2020

Postoperative radiotherapy of glioblastoma multiforme: analysis and critical assessment of different treatment strategies and predictive factors

1 reference

12 December 2020

Reirradiation of primary brain tumours: survival, clinical response and prognostic factors

1 reference

12 December 2020

Patterns of failure following CT-based 3-D irradiation for malignant glioma.

1 reference

12 December 2020

Single dose radiosurgical treatment of recurrent previously irradiated primary brain tumors and brain metastases: final report of RTOG protocol 90-05

1 reference

12 December 2020

Bevacizumab plus irinotecan in recurrent glioblastoma multiforme

1 reference

12 December 2020

Salvage therapy in patients with glioblastoma: is there any benefit?

1 reference

12 December 2020

Hypofractionated stereotactic radiotherapy for brain metastases--results from three different dose concepts

1 reference

12 December 2020

Results of re-irradiation of primary intracranial neoplasms with three-dimensional conformal therapy.

1 reference

12 December 2020

Chemotherapy in the treatment of recurrent glioblastoma multiforme: ifosfamide versus temozolomide

1 reference

12 December 2020

Survival and quality of life after hypofractionated stereotactic radiotherapy for recurrent malignant glioma.

1 reference

12 December 2020

Retrospective analysis of re-irradiation in malignant glioma: a single-center experience.

1 reference

12 December 2020

The value of reoperation for recurrent glioblastoma.

1 reference

12 December 2020

Radiochemotherapy of malignant glioma in adults. Clinical experiences

1 reference

12 December 2020

Comparison of short-course versus long-course whole-brain radiotherapy in the treatment of brain metastases

1 reference

12 December 2020

Comparison of stereotactic radiosurgery and brachytherapy in the treatment of recurrent glioblastoma multiforme

1 reference

12 December 2020

Efficacy and tolerability of temozolomide in an alternating weekly regimen in patients with recurrent glioma.

1 reference

12 December 2020

Single dose versus fractionated stereotactic radiotherapy for recurrent high-grade gliomas.

1 reference

12 December 2020

Phase II trial of lomustine plus temozolomide chemotherapy in addition to radiotherapy in newly diagnosed glioblastoma: UKT-03.

1 reference

12 December 2020

Stereotactic radiosurgery (SRS): treatment option for recurrent glioblastoma multiforme (GBM).

1 reference

12 December 2020

CT-guided interstitial HDR brachytherapy for recurrent glioblastoma multiforme. Long-term results.

1 reference

12 December 2020

Treatment of recurrent malignant gliomas with stereotactic intensity modulated radiation therapy.

1 reference

12 December 2020

A comparison of treatment results for recurrent malignant gliomas

1 reference

12 December 2020

Treatment of recurrent glioblastoma multiforme using fractionated stereotactic radiosurgery and concurrent paclitaxel.

1 reference

12 December 2020

A phase II study of temozolomide vs. procarbazine in patients with glioblastoma multiforme at first relapse

1 reference

12 December 2020

High activity iodine-125 interstitial implant for gliomas

1 reference

12 December 2020

Whole-brain radiotherapy with 20 Gy in 5 fractions for brain metastases in patients with cancer of unknown primary (CUP).

1 reference

12 December 2020

Therapeutic options for recurrent high-grade glioma in adult patients: recent advances

1 reference

12 December 2020

Permanent iodine 125 brachytherapy in patients with progressive or recurrent glioblastoma multiforme

1 reference

12 December 2020

Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma

1 reference

12 December 2020

GliaSite brachytherapy for treatment of recurrent malignant gliomas: a retrospective multi-institutional analysis

1 reference

12 December 2020

10.1007/S00066-009-1969-9

Identifiers

DOI

1 reference

15 February 2018

PubMed ID

19240998

1 reference

15 February 2018